Introduction
Autopsies, once commonplace, have become increasingly rare. In the 1950s, autopsies were performed on half of all deaths; by 1995, this percentage dropped to as low as 7%. 1 This decline has been attributed to clinical, economic and medico-legal factors. [2] [3] [4] [5] [6] However, autopsies have historically been used for educational purposes, research and for understanding disease patterns and processes. 3, 4, [6] [7] [8] [9] [10] [11] Furthermore, they provide a means of quality assurance, ultimately improving treatments and outcomes for other patients.
It has been suggested that autopsies have become less useful over time 4 and that advances in diagnostic medical technology and clinical skills have contributed to this phenomenon. 12, 13 Despite such developments, disagreements between ante-mortem and post-mortem (PM) diagnoses remain both problematic and systemic. 5, [14] [15] [16] [17] Interest has grown in blood and marrow transplantation (BMT) cases; recent studies 12, 18 have examined the accuracy of diagnoses and the use of autopsies in this group.
Based on a comprehensive analysis of autopsies performed at the Manitoba BMT program, the present study had several objectives: firstly, to examine the factors that predict the decision to perform the autopsy; secondly, to assess whether meaningful information is obtained from the autopsy; thirdly, to determine whether rates of autopsy are changing; fourthly, to ascertain whether advances in antemortem diagnostic techniques can justify a diminished need for autopsies.
Patients and methods
All patients undergoing blood or marrow transplantation since the inception of the Manitoba BMT program in January 1990 until December 2004 were identified from a computerized database. Patients who died at any time following the commencement of the preparative regimen therapy were eligible for review. The following variables were recorded: basic clinical characteristics of the patient; transplant characteristics; the date, time and place of death. The clinical cause of death was also recorded. If an autopsy was performed, the type of physician ordering the autopsy (BMT physician, intensive care unit physician, medical examiner or other physician) was identified. The autopsy diagnoses were reviewed by at least two BMT physicians certified in hematology/oncology. A decision was made as to whether autopsy findings were in full agreement with the clinical diagnosis at the time of death or whether a minor or major disagreement was present. Criteria for disagreement between clinical and pathological diagnoses or causes of death were based on the system used by Allan et al., 3 originally described by Goldman et al. 19 A major disagreement was defined as a difference in the primary diagnosis that would have led to alternative therapeutic options that may have changed the clinical outcome. A minor disagreement related to discordance in a secondary diagnosis, or a diagnosis, that was unlikely to have affected clinical outcome. Agreements included both clarifications and confirmations of clinical diagnosis.
The overall number of in-patient deaths at Health Sciences Centre, Winnipeg, as well as the total number of autopsies performed at this tertiary referral and teaching hospital were identified for the period January 1992 to December 2004 (accurate data were not available prior to 1992). Rates of autopsies related to the total number of deceased patients were calculated on an annualized basis for the BMT cohort and the general hospital cohorts.
In the BMT cohort, the characteristics of deceased patients receiving and not receiving PMs were compared by Student's t-test, w 2 or Fisher's exact test. Independent factors that predicted the undertaking of a PM procedure were identified by logistic regression analysis. A P-value o0.05 was considered statistically significant. Results were tabulated using odds ratios with 95% confidence intervals.
Results
During the 13-year period, 476 adult patients underwent BMT and 225 died. Of the deceased, 48 received an autopsy; 41 (85%) were full autopsies and 7 (15%) were limited to specified organs. Characteristics of the deceased patients along with comparisons between those undergoing or not undergoing an autopsy are listed in Table 1 . There was incomplete autopsy reporting in only one patient.
Factors predicting PM procedures
The majority of these procedures (83%) were ordered by supervising BMT physicians. Eight autopsies (17%) were performed by the medical examiner. As indicated in Table 1 , the age and sex of the PM and non-PM groups were similar. The majority of the PM patients were allogeneic transplant recipients (77%), and most PM patients (92%) were being treated for acute and chronic leukemias or lymphoproliferative disorders. The PM patients died predominantly on the BMT ward or intensive care unit, whereas the majority of the non-PM patients died on other wards or at home. A greater proportion of the PM group died prior to day 100 post-BMT (77%) with only three patients (6%) undergoing PM after day 365 post-BMT. This differed significantly from the non-PM patients in which 61 (34%) died after day 365. Rates of acute and chronic GVHD were similar in the PM and non-PM groups. Overall, PM patients were more likely to have died during weekends than during office hours (48 vs 29%). By multivariate analysis, independent factors predicting the undertaking of a an autopsy included patients undergoing allogeneic transplants, patients dying on the intensive care or BMT units and those dying before day 100 post-BMT ( Table 2 ).
The changing rates of autopsies As illustrated in Figure 1 , autopsy rates in all patients at Winnipeg Health Sciences Centre dropped between 1992 and 2004. Similarly, autopsy rates declined in patients within the BMT program. Despite this downward trend, year of death was not a statistically significant predictor of performing autopsies in multivariate analysis (Table 2) .
Discordance in clinical and PM causes of death
There was a major discrepancy between clinical and PM diagnoses in 16 (34%) of the 47 available autopsy reports; minor discrepancies were present in 14 (30%) reports Table 1 Characteristics of deceased patients (N ¼ 225)
No autopsy (n ¼ 177) ( Table 3) . General agreement or diagnostic clarification occurred in 17 (36%) patients. Although the greatest number of major disagreements occurred in 2000-2004, there was no statistical difference between the grouped years in which a major or minor disagreement was made.
As evident in Table 4 , infectious disease diagnoses accounted for 10 (63%) of major disagreements.
Discussion
The decline in autopsy rates in medical and surgical patients is well documented. 1, 3, 4, [20] [21] [22] Given that BMT is a relatively recent medical development, one would expect it to generate interest in explaining causes of death; however, the present study shows that autopsy rates among these patients have declined between 1990 and 2004. This decline matched the diminishing rates of autopsy in the associated teaching hospital and is incongruent with the results of Allan et al.
3 who reported well-preserved rates during their 11-year study period. Their observation may be a function of their center-wide policy of conducting regular morbidity and mortality meetings; this policy has not been in formal existence in our BMT program until 2004. Whether financial incentives dictate autopsy rates remains unclear. Our center has a similar remuneration structure to that of the Canadian center described by Allan et al. Thus, fee structures could not explain the differences between the two studies. Nonetheless, we recognize that underresourced pathology services may discourage an autopsy service.
The day of the week may affect autopsy rates. 2 Accordingly, we stratified autopsy times into three specific periods (office hours, weekdays after hours and weekends). We found an increased trend for autopsies on weekends. Physicians involved in the care of the BMT patients at our center are relatively stable, and it would be rare for the weekend medical staff to be unfamiliar with patients or their family members. In addition, physicians working on weekends may paradoxically have more available time to review the patient and to counsel family members when there are no competing outpatient clinics, administrative duties or research schedules. Disagreements between ante-mortem and PM diagnoses for BMT patients have been reported by others; 3, 12 however, the extent of our disagreements is striking. With combined disagreements at 64% (34% major, 30% minor), our study has one of the highest rates of discordance as compared to similar studies. Allan et al. had a rate of 27% (16% major, 11% minor). More recently, Hofmeister et al. 12 had approximately 26% discordance (4% major, 23% minor). Nevertheless, our results are comparable with Xavier et al. 8 whose study in hematological malignancies noted a discordance of 68.6% (31.3% major, 37.3% minor). Our results are also similar to Ferguson et al. 18 whose 592 patients from a diverse population had 39.1% disagreement (15.6% major, 23.5% minor). The variability in disagreement rates is unlikely to be a function of the time period (since Allan et al. examined a period similar to our own), but rather to the inherent differences in patient selection for autopsy. As with many studies, it is plausible that there was a greater tendency for patients with highly complicated clinical courses to have autopsies.
Despite the readily available array of diagnostic testing for BMT patients, clinical and autopsy disagreements remain high. Hence, clinical diagnoses cannot solely be relied upon. 3, 6, 8, 18, 23 The majority of disagreements related to difficulties in the evaluation of relapsed or persistent disease, GVHD and infectious diseases. Infection is a major cause of death in BMT patients 11, [23] [24] [25] [26] [27] [28] and accounts for most of the major disagreements (63%) in our study.
The high rates of discrepancies underscore the inadequacy of ante-mortem diagnostic procedures which, although increasingly available and sophisticated, are not entirely sufficient in the clinical care and management of BMT patients. Others have argued that advances in antemortem diagnostic procedures have made autopsy use expendable. 12, 13 However, our data (Table 3) demonstrate that there are no statistically significant differences in major disagreements between the early years (1990) (1991) (1992) (1993) (1994) and the most recent years (2000) (2001) (2002) (2003) (2004) of the study. Furthermore, we observed a progressive decline in number of agreements and a concurrent increase in the number of major disagreements when comparing the same time periods. Although this difference was not statistically significant, the data nonetheless support the assertion that there has been no difference in disagreements over time.
It is arguable that more modern diagnostic tests would have actually improved the clinical outcome of patients. Although invasive aspergillosis may now be detected by the serum galactomannan assay, 29 this test is limited by its restricted test characteristics; a false-positive rate as high as 14% has been reported. [29] [30] [31] In our study, even if all disagreements due to Aspergillus species were removed, 25 of the 30 PM disagreements would remain. Although a strategy for CMV surveillance of peripheral blood leukocytes with pre-emptive ganciclovir therapy has been in practice at our center since 1997, 32 CMV surveillance did not appear to affect the rates of disagreement before and after its introduction (Table 3) . Overall, our experience suggests that recent advances in pre-mortem diagnostic testing have not improved the rate of disagreements over time.
A strength of this study is that our data does not suffer from incomplete, missing or destroyed patient records. Only 1 (2%) of our records was missing as opposed to the 11 (9%) that were available in the Hofmeister et al. 12 In addition, our BMT data managers undertook active followup of patients and complete reporting was ensured on all deceased BMT patients regardless of their time and place of death.
One weakness of our study is the lack of a large patient population. In addition, selection bias may account for differences in disagreement rates between this and other studies. We suggest that further studies be conducted using a greater number of patients with a systematic selection of candidates for autopsy before any recommendation of eliminating or precluding medical autopsies is accepted.
The practice of BMT continues to evolve. There have been recent and dramatic changes in patient and donor selection, the use of reduced-intensity preparative regimens, as well as novel GVHD and antimicrobial strategies. In this setting, the array of procedure-related toxicities and patterns of disease relapse will shift. This reinforces the need to retain the autopsy as a vital component in the care of BMT patients and in research relevant to the modern era of BMT.
In conclusion, our study indicates that fewer deceased BMT patients are undergoing autopsies compared to the early years of the transplant program. Autopsies were more likely to occur on weekends, prior to day 100 post-BMT and on the BMT or intensive care units. Autopsies were useful, having corrected the clinical diagnosis in a large number of cases. Furthermore, our data refute the contention that modern diagnostic techniques and clinical care negate the need for autopsies.
